The class II transactivator (CIITA), the master regulator of the tissue-specific and interferon gammainducible expression of major histocompatibility complex class II genes, synergizes with the histone acetylase coactivator CBP to activate gene transcription. Here we demonstrate that in addition to CBP, PCAF binds to CIITA both in vivo and in vitro and enhances CIITA-dependent transcriptional activation of class II promoters. Accordingly, E1A mutants defective for PCAF or CBP interaction show reduced ability in suppressing CIITA activity. Interestingly, CBP and PCAF acetylate CIITA at lysine residues within a nuclear localization signal. We show that CIITA is shuttling between the nucleus and cytoplasm. The shuttling behavior and activity of the protein are regulated by acetylation: overexpression of PCAF or inhibition of cellular deacetylases by trichostatin A increases the nuclear accumulation of CIITA in a manner determined by the presence of the acetylation target lysines. Furthermore, mutagenesis of the acetylated residues reduces the transactivation ability of CIITA. These results support a novel function for acetylation, i.e., to regulate gene expression by stimulating the nuclear accumulation of an activator.
Major histocompatibility complex (MHC) class II genes encode heterodimeric cell surface molecules that are essential for the presentation of foreign antigenic peptides to helper T cells. Human and mouse genes are expressed in antigen-presenting cells as well as in various cell types upon gamma interferon (IFN-␥) stimulation (16, 34, 52) . The expression of these genes occurs mainly at the transcriptional level and is regulated by an array of functional cis elements (H/W, X, and Y) that are conserved among all class II genes (16) . Transcription of class II genes is orchestrated by the assembly of a higher-order multiprotein complex on the promoter and requires recruitment of the class II transactivator, CIITA (6, 34) . Both constitutive and IFN-␥-inducible expression of class II genes are determined by the presence of CIITA in a variety of cell types (8, 34, 49) . Functional analysis of the structure of CIITA revealed the presence of a C-terminal region required for promoter recruitment (44, 59) and an N-terminal acidic transactivation domain that can contact the basic transcriptional machinery (13, 35) .
Recently, we and others have demonstrated that the histone acetylase CREB binding protein (CBP) interacts with CIITA and functions as a coactivator for both B-cell-specific and IFN-␥-induced transcription of MHC class II genes (13, 30) . Consequently, expression of MHC class II genes was suppressed by the adenovirus E1A protein (30) , which is known to strongly bind to and inhibit CBP action (1, 33) .
The discovery that transcriptional coactivators have histone acetylase activity (4, 41) provided important insights into the process that links chromatin acetylation to transcriptional activation (20, 31, 50) . CBP/p300 and the associated factor PCAF collaborate with many transcription factors as well as with other coactivators, such as SRC-1 and ACTR, to regulate cell proliferation and differentiation (29) .
In addition to histones, CBP/p300 and PCAF can acetylate nonhistone proteins such as TFIIE, TFIIF (25) , p53 (17, 32, 45) , EKLF (58) , GATA-1 (7, 23) , HMG I (Y) (38) , HMG17 (21) , ACTR (9) , Tat (27) , MyoD (46) , and E2F1 (36) .
In this paper we demonstrate that, similarly to CBP, PCAF binds to and enhances the action of CIITA as an MHC class II gene coactivator. The weak inhibitory activity of E1A mutants defective for binding to either coactivator shows that the action of CIITA depends on the independent and redundant recruitment of either CBP or PCAF. Furthermore, we demonstrate that PCAF and CBP acetylate specific lysine residues within a novel nuclear localization sequence (NLS) of CIITA. We show that CIITA exits from the nucleus in a CRM-1-dependent manner. Acetylation leads to an increase of CIITA accumulation in the nucleus. Mutations of acetylation-target lysines reduce the nuclear levels and transcriptional ability of CIITA. Based on these data, we propose a novel role of acetylation to regulate class II gene expression by affecting the nuclear accumulation of CIITA.
lysine mutants were constructed with the Gene Editor in vitro site-directed mutagenesis system from Promega. The mutagenic primers were K141,144R (5Ј-GTTGGGCAGAGAAGTCAGAGAAGACCCTTC) and K156,159R (5Ј-G CAGACCTGAGGCACTGGAGGCCAGCTGAG). All constructions were verified by sequencing.
In vitro protein-protein interaction experiments. Fragments of PCAF and CIITA were subcloned into pGEX vectors (Pharmacia) in frame with glutathione S-transferase. Approximately 2 g of fusion proteins was immobilized to glutathione-Sepharose beads and incubated with in vitro-translated and 35 Slabeled (TNT; Promega) CIITA or PCAF protein in a buffer containing 150 mM KCl, 20 mM HEPES (pH 7.9), 0.1% NP-40, 5 mM MgCl 2 , and 0.2% bovine serum albumin and supplemented with protease inhibitors. Reactions were carried out at 4°C for 5 h, and the mixtures were washed three times in the same buffer without bovine serum albumin. Bound proteins were subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and detected by autoradiography.
Immunoprecipitation (IP) and Western blot analysis. For in vivo proteinprotein interactions, COS-1 cells in 100-mm-diameter dishes were transfected with 5 g of each plasmid using the calcium phosphate method. Whole-cell extracts were prepared in lysis buffer containing 10 mM Tris-HCl (pH 8), 170 mM NaCl, 5 mM EDTA, 0.5% NP-40, 1 mM dithiothreitol, and protease inhibitors. Extracts equivalent to about 5 ϫ 10 6 cells were incubated for 16 h at 4°C with anti-Flag M2 agarose (Sigma). The immunoprecipitated samples were washed four times with lysis buffer containing 250 mM NaCl and subjected to SDS-PAGE. Western blot analysis was performed using monoclonal anti-HA (Santa Cruz), anti-Flag (Kodak), or anti-green fluorescent protein (GFP) (Clontech) antibodies.
In vitro acetylation assays. 
RESULTS
The acidic activation domain of CIITA binds to PCAF in vitro and in vivo. Previous studies have shown that CBP, a protein acetylase, synergizes with CIITA for maximal expression of MHC class II genes (30) . In the present study, we decided to investigate the role of PCAF, an acetylase that associates with CBP (56) and forms a higher-order multiprotein complex (PCAF complex [42] ), in MHC class II gene transcription.
To identify the CIITA region involved in PCAF binding, we used different CIITA fragments fused to GST (Fig. 1A) . CIITA fragments containing the amino-terminal transcription activation domain of CIITA (fragments 1-408 and 1-114 [lanes 5 and 6, Fig. 1B] ) interacted with PCAF. Interestingly, the same amino-terminal region (amino acids 1 to 114) was also responsible for binding to CBP (30) . In an attempt to map more precisely the CBP and PCAF interaction sites within the N-terminal domain of CIITA, the region extending between amino acids 1 to 151 was divided into three smaller parts. As shown in Fig. 1B , both PCAF and CBP bind predominantly to the first 80 amino acids of CIITA (Fig. 1B lanes 7, 12, and 18 ), which contain an ␣-helix required for full activity of CIITA (13) .
To map the region of PCAF that binds CIITA, we used the PCAF deletion constructs depicted in Fig . Further analysis showed that the HAT domain (contained in fragments 1-654 and 511-654 in lanes 6 and 9) interacted weakly with CIITA whereas the region that harbors the ADA binding domain (fragment 653-736) showed a strong interaction (lane 10). The Bromo domain was devoid of the ability to interact (lanes 11 and 12). Taken together, these results show that the region of PCAF that binds to CIITA is distinct from the region required for binding to CBP and to nuclear receptors and coactivators.
To examine whether PCAF and CIITA associate in vivo, we cotransfected COS-1 cells with expression vectors encoding Flag-tagged PCAF and HA-tagged CIITA and performed coimmunoprecipitation experiments. Figure 3 shows that the intact CIITA protein interacts with PCAF (lane 1') whereas a truncation of the first 102 amino acids (which are required for binding in vitro to PCAF) does not (lane 2'). We also determined which regions of PCAF are important for in vivo association with CIITA. A PCAF protein that contains only the first 511 amino acids (PCAF 1-511) and a PCAF that lacks the ADA binding region (amino acids 653 to 736) (PCAF ⌬ADA) cannot interact with CIITA (lanes 4' and 5', respectively), in contrast to the wild-type protein (lane 3'). Therefore, the in vivo interaction analysis correlates well with the in vitro data presented previously.
PCAF coactivates MHC class II genes. We next asked if PCAF was able to coactivate MHC class II genes. HeLa cells were transiently transfected with the E␣ MHC class II promoter construct along with a PCAF-expressing plasmid. The activity of the promoter was determined from untreated cells or cells after a 20-h treatment with IFN-␥, which is known to induce CIITA expression, which in turn induces class II gene transcription. Although the presence of PCAF did not significantly affect the basal promoter activity, it strongly enhanced (up to sevenfold) the IFN-␥-induced expression (Fig. 4A ).
Since the effect of IFN-␥ on class II gene expression is mediated by CIITA, we examined the ability of PCAF to directly coactivate exogenously provided CIITA. Transfection of a CIITA expression vector resulted in activation of the E␣ class II promoter in HeLa cells, whereas PCAF alone did not produce any effect (data not shown). Coexpression of PCAF augmented the CIITA-mediated activation (Fig. 4B) . Therefore, PCAF and CIITA synergistically activate class II promoter transcription. Deletion of the CBP interaction domain of PCAF (amino acids 1 to 372) did not abolish the ability of PCAF to stimulate CIITA-dependent class II transcription (PCAF-⌬N; Fig. 4B ). Thus, the ability of PCAF to stimulate CIITA activity is mainly CBP independent. A PCAF protein bearing mutations in the HAT domain (PCAF HAT Ϫ [28] ) has a lowered capacity to coactivate CIITA compared to that of the wild-type protein. This suggests that histone or protein acetylation contributes to the synergy observed between PCAF and CIITA. Two PCAF deletion mutants that do not interact with CIITA (PCAF 1-511 and PCAF ⌬ADA [ Fig. 4B ]) were unable to coactivate CIITA. This result underlines the importance of strong PCAF binding to CIITA for the coactivation of class II genes.
To evaluate the relative importance of CBP and PCAF in MHC class II regulation, we took advantage of E1A mutants ( Fig. 4C and D) . Cotransfection of the 13s E1A or a mutant defective for pRb binding, Rb m (mutant TK496 in which amino acids 38 to 44 are mutated to alanine [3] ), showed strong suppression, in contrast to a CR1 deletion, which was a very weak inhibitor ( Fig. 4C and D) . Thus, sequestration of either coactivator by E1A is not sufficient to reduce promoter activation. Taken together, these results demonstrate the functional redundancy of PCAF and CBP, which can independently enhance the action of CIITA.
PCAF and CBP acetylate CIITA. PCAF and CBP are protein acetyltransferases that use as substrates both histones and other proteins (reviewed in references 5 and 29). Therefore, we investigated whether CIITA could be acetylated by PCAF and CBP. Figure 5B shows that PCAF can acetylate CIITA in vitro (lane 1). Deletion analysis indicated that acetylation of CIITA is restricted to amino acids 129 to 174 (lane 7). This region contains two pairs of closely spaced lysines, which are well conserved between human and mouse CIITA (Fig. 5A) . Mutation of the first pair, K141,144 (designated mK1), abolished acetylation (lane 10), whereas mutation of the second pair, K156,159 (designated mK2), had no effect (lane 11). Therefore, PCAF acetylates the first lysine pair, K141,144. Further mutagenesis indicated that lysine 144 is the acetylation target of PCAF (lane 13). A similar result was obtained when acetylation was performed using PCAF immunoprecipitated from transfected COS-1 cells (lanes 14 and 15) .
We next checked the ability of CBP to acetylate CIITA. Since a bacterially produced CBP HAT domain was unable to acetylate CIITA, we used CBP immunoprecipitated from transfected COS cells. As shown in Fig. 5C , CBP can acetylate CIITA. Deletion analysis limited the area that was acetylated to the first 174 residues (lane 2). Using mutant versions of the region from amino acids 1 to 174, we determined that CBP acetylates the lysine pair K141,144 of CIITA (lane 7) but does not acetylate the lysine pair K156,159 (lane 8). It is unlikely that acetylation of CIITA is due to some other acetylase that To test whether the in vitro-detected acetylation sites are also targets for acetylation in vivo, we performed metabolic labeling of cells expressing GFP-tagged CIITA proteins. Figure 5D shows that a truncated protein that contains the first 114 amino acids of CIITA and is devoid of any lysine is not labeled (lane 3), excluding the possibility that we detected amino-terminal acetylations. The wild-type 1-408 CIITA protein was efficiently labeled (lane 1), whereas mutant K141,144R showed severely reduced acetylation (lane 2). The intact CIITA protein was also acetylated in vivo (not shown), although the effect of mutating lysines 141 and 144 was less clear, presumably because additional lysine targets might exist in the protein. The conclusion of our acetylation analysis is that the lysine pair K141,144 of CIITA is acetylated both in vitro and in vivo. From now on, mutants K141,144R and K156,159R will be called mK1 and mK2, respectively.
CIITA is acetylated on an NLS. The CIITA region which contains the acetylated lysine residues (Fig. 5A ) is highly conserved between human and murine CIITA (47) and has similarity to a bipartite NLS. To test the ability of this region to mediate CIITA import in the nucleus, we used fusions of CIITA with GFP. Fusion of GFP with the first 130 amino acids of CIITA (1-130) produced a protein that was evenly distributed, like the GFP protein itself, whereas a fusion of the first 175 amino acids (1-175) showed nuclear localization (Fig. 6) , suggesting that NLSs may reside in this fragment. Accordingly, an amino-terminal deletion of 174 amino acids (175-1130) rendered CIITA cytoplasmic. The NLS was further restricted between amino acids 129 to 174, as indicated by the corresponding GFP fusion, which showed a prominent nuclear fluorescence (Fig. 6) . Furthermore, replacement of lysines 141 and 144 (mK1) or 156 and 159 (mK2) with arginines in the context of GFP-CIITA/129-174 generated proteins that were homogeneously distributed in both the nucleus and cytoplasm. Therefore, the region extending from lysines 141 to 159 is a bipartite NLS that requires both motifs for its function. 
Acetylation increases CIITA accumulation in the nucleus.
Since acetylation target lysines reside within an NLS, we tested whether acetylation might affect the nuclear localization of the protein. To do this we used GFP fusions to study the subcellular distribution of the acetylation-deficient mutant mK1 in comparison to mK2 and the wild-type protein. The GFP-CIITA fusion protein was distributed in both the nucleus and the cytoplasm, whereas mK1 and mK2 mutants showed a predominantly cytoplasmic localization (Fig. 7, upper panel) . More specifically, as shown in Table 1 , wild-type CIITA showed stronger nuclear than cytoplasmic (N Ͼ C) distribution in 33% of cells, in contrast to only 0.5% of cells expressing either mK1 or mK2 mutant protein. Furthermore, mK2 was homogeneously (N ϭ C) distributed in 14.4% of cells, compared to only 3.5% of mK1 protein. Interestingly, treatment with leptomycin B (LMB) (54), a well-characterized inhibitor of CRM-1-mediated nuclear export (14, 15) , led to strong nuclear localization of CIITA (Fig. 7, LMB) . Mutants mK1 and mK2 also responded to LMB (Fig. 7, LMB) to a lesser extent, suggesting that they retain residual import activity and are able to accumulate in the nucleus when export is inhibited. As a control, we showed that an N-terminally truncated protein that lacks the NLS and contains amino acids 175 to 1130 was also cytoplasmic but did not respond to LMB (Fig. 7) . Thus, the observed cellular distribution of CIITA is determined by both nuclear import and a CRM-1-dependent export.
To correlate the subcellular distribution of CIITA with its acetylation state, we used the deacetylase inhibitor trichostatin A (TSA) (57) . HeLa cells were transfected with GFP fusions of wild-type or mutant CIITA and GFP-p65, and the cytoplasmicnuclear distribution of these proteins was determined by fluorescence microscopy. Figure 8 shows that the addition of TSA strongly enhanced the nuclear accumulation of GFP-CIITA but did not significantly affect the subcellular distribution of GFP-p65, which is not acetylated by CBP or PCAF (38) and shuttles between the nucleus and cytoplasm in a regulated fashion (2, 18) . Table 1 quantitates the nuclear and cytoplasmic distribution of wild-type, mutant CIITA, and p65 before and after addition of TSA. A 24-h treatment with TSA led to strong redistribution of GFP-CIITA toward the nuclear compartment (N Ͼ C cells increased from 33 to 77%) with a To obtain direct proof that CIITA acetylation by PCAF affects its nuclear and cytoplasmic distribution, we cotransfected GFP-CIITA and PCAF expressing plasmids in COS-1 cells. Exogenously expressed PCAF was able to increase the nuclear levels of CIITA. As shown in Fig. 9A and C, PCAF coexpression promoted the nuclear localization of GFP-CIITA whereas a PCAF HAT Ϫ protein was significantly less effective. Cells expressing high levels of PCAF almost invariably presented strong nuclear localization of CIITA. Figure 9B exemplifies this by showing that nuclear GFP-CIITA localization coincides with PCAF expression. The subcellular distribution of the GFP vector alone was not affected by coexpressing PCAF (data not shown). The NLS mutant mK2 also responded strongly to PCAF (the percentage of cells bearing nuclear fluorescence was raised from 0.7 to 33%), and this effect was dependent on HAT activity (Fig. 9C) . However, the response of the NLS acetylation mutant mK1 was significantly lower and did not depend on the presence of an intact HAT domain (Fig.  9C) . Deletions of PCAF that do not retain strong interaction with CIITA, such as PCAF 1-653 (Fig. 9C) or PCAF⌬ADA (data not shown), were not able to relocate CIITA to the nucleus. Thus, the effect of PCAF on CIITA localization depends on its ability to both bind and acetylate. Taken together, these results show that acetylation by PCAF or inhibition of deacetylation leads to increased nuclear levels of CIITA by targeting lysines 141 and 144.
We next investigated the consequences of CIITA acetylation on MHC class II gene transcription. For this purpose, we examined the abilities of wild-type and mutant CIITA proteins to activate a class II promoter. Figure 10 shows that the acetylation NLS mutant mK1 had a strongly reduced ability to transactivate a class II promoter (25% of the wild-type level). In contrast, the NLS mutant mK2 retained 70% of wild-type activity (Fig. 10) . The differential activity of the two mutant proteins correlated with their difference in subcellular CIITA distribution (Table 1) . To determine whether we could influence the activity of wild-type and mutant CIITA by increasing their nuclear content, we produced fusions carrying at their N terminus the NLS of simian virus 40 (SV40). The addition of the SV40 NLS rendered all these proteins nuclear (data not shown), leading to an increase of their activity (Fig. 10) . More specifically, the activity of the acetylation mutant mK1 was restored and reached a level comparable to that of mK2. Therefore, enhanced nuclear accumulation of CIITA leads to higher transactivation of class II genes.
DISCUSSION
In this study we examined the role of PCAF in the transcriptional regulation of MHC class II genes. We showed that in addition to CBP (13, 30) , PCAF binds to the class II transactivator and is able to augment the IFN-␥-or CIITA-mediated transcriptional activation of class II genes. Binding of PCAF or CBP leads to acetylation of CIITA at lysines that reside within a NLS. We further demonstrate that CIITA exits the nucleus via a CRM-1-dependent pathway. Based on the effect of the deacetylase inhibitor TSA and the action of PCAF to increase the nuclear levels of CIITA through acetylation of these lysines, we propose that a novel function of acetylation is to regulate the activity of an activator by increasing nuclear accumulation.
Both CBP and PCAF are essential for MHC class II gene transcription. We demonstrate here that PCAF binds to and synergizes with CIITA to induce class II gene transcription. This effect requires a strong interaction between the two proteins and also the acetyltransferase activity of PCAF. The full effect of PCAF on a class II promoter is derived from its combined action on the recruitment of the transcriptional machinery and acetylation of chromatin and, interestingly, CIITA itself. We have observed that CBP and PCAF cannot bind simultaneously to CIITA in vitro (data not shown). This is not unexpected considering the short CIITA region-the first 80 amino-terminal amino acids-with which they both interact. In this study we show that E1A oncoprotein, which inhibits the synergy between CIITA and CBP (30) , also interferes with the interaction between CIITA and PCAF. This interference might result from the prevention of CIITA binding to PCAF, since E1A (43) and CIITA bind to the same region of PCAF. E1A mutants that cannot bind to either CBP or PCAF (3, 43) have equally reduced ability to inhibit the activity of CIITA on an MHC class II promoter. Taken together, the physical interaction properties of CIITA with those coactivators and the pattern of suppression by various E1A mutants are in support of their redundant and independent recruitment by CIITA.
CBP and PCAF are histone and factor acetyltransferases that participate in the formation of diverse multisubunit complexes. CBP is a component of the RNA polymerase II holoenzyme (39), whereas PCAF is found in human cells in a complex that is the equivalent of the yeast SAGA and includes human counterparts of yADA2, yADA3, ySpt3, and histonelike TAFs (42) . Thus, the ability of CIITA to recruit CBP and PCAF acetyltransferases independently provides it with the capability to modulate chromatin structure by alternative interactions with multiple complexes. CIITA is required for the establishment of an "occupied" class II promoter configuration in IFN-␥-induced fibroblasts but not in B lymphocytes (53, 55) . This difference may be due to cell-type-specific chromatinmodifying complexes that interact with CIITA. There is little information regarding the regulation of activity of CBP and PCAF themselves in different cells and in response to different signals (37) . Therefore, we assume that conditions that regulate the availability and stoichiometry of each of the two coactivators may also affect the function of CIITA. CIITA acetylation as a regulatory mechanism for its subcellular distribution. We show that acetylation can regulate the subcellular localization of CIITA, which shuttles between the nucleus and the cytoplasm. CIITA shuttling is achieved by the combined action of nuclear import and CRM-1-dependent nuclear export. The latter involves nuclear export sequences recently characterized in CIITA (C. Spilianakis et al., unpublished data). We identify here a bipartite NLS in the aminoterminal region of CIITA. Another NLS, which was deleted in a bare lymphocyte syndrome patient, was recently identified in the carboxy-terminal region (amino acids 955 to 960) (11) . It seems that both NLSs are required for efficient nuclear import and function of CIITA. The first half of the amino-terminally located NLS contains lysines 141 and 144, which are targeted for acetylation by CBP and PCAF. We demonstrate that conditions favoring acetylation, such as coexpression of PCAF or inhibition of deacetylases, lead to increased nuclear levels of CIITA. This effect requires (i) direct physical interaction between PCAF and CIITA and (ii) lysine pair K141,144. When nuclear import of CIITA is compromised by the NLS mutation mK2, the action of acetylation to control nuclear levels becomes even more apparent. The NLS acetylation mutant mK1 is not affected by the acetylase activity of PCAF, although it is relocated to a small extent in the nucleus by PCAF in a HATindependent manner. This effect underlines the ability of simple binding to PCAF to provoke sequestration in the nucleus of mK1 and, to a lesser extent, of mK2 and the wild-type molecule. The deacetylase inhibitor TSA mimicked, although to a lesser extent, the effect of PCAF on the mK2 mutant. A plausible interpretation of this could be that TSA is acting indirectly and thus with slower kinetics than PCAF. Increased nuclear levels of CIITA can be attributed to either increased import or decreased export. Since acetylases such as PCAF are nuclear proteins, we favor the second hypothesis, although the first cannot be formally excluded. These alternative mechanisms are currently under investigation.
The acetylation state of CIITA is important for its activity. The ability of a HAT-deficient PCAF to coactivate CIITA is lowered in comparison to that of the wild-type molecule but is not abolished. This lack of abolition may be attributed to the ability of a HAT Ϫ PCAF to recruit the acetylase CBP. The importance of CIITA acetylation on the transcriptional activation of a class II promoter is shown by the reduced transactivation capability of the acetylation mutant mK1 compared to the wild type and the NLS mutant mK2. Since both mutations retain a residual ability for nuclear import, as judged by the action of LMB (Fig. 7) , the difference in transactivation capability between mK1 and mK2 underlines the importance of acetylation in CIITA function.
Acetylation is believed to induce structural alterations that could affect protein-DNA or protein-protein interactions. For CIITA, acetylation might induce a conformational change, which alters the way in which CIITA interacts with the nuclear export machinery. Alternatively, it is possible that acetylated CIITA is retained in the nucleus due to association with an architectural nuclear structure (the nucleoskeleton) (10, 22, 24, 26) , possibly via intermediary molecules like PCAF. Acetylation might also facilitate or stabilize CIITA recruitment on MHC class II promoters. Conversely, deacetylation could reduce nuclear levels and promoter complex assembly, thus limiting the ability of CIITA for transcriptional activation.
It was recently reported that GTP binding is required for nuclear localization and activation of target genes by CIITA (19) . The possibility of a functional connection of these two posttranslational modifications-acetylation and GTP binding-to regulate the subcellular distribution and activity of CIITA is under investigation.
Control of intracellular protein trafficking is a novel mechanism through which acetylation may regulate the action of a transcriptional activator or coactivator such as CIITA. Remarkably, in two other cases, acetylated residues reside within NLSs. Both acetylation sites of p53, by CBP and PCAF, reside in NLSs (45) , whereas acetylated lysines of EKLF also overlap an NLS (58) . It will be interesting to investigate whether in these cases the acetylation state of the proteins affects their subcellular distribution.
In conclusion, our data show that PCAF activates the transcription of MHC class II genes through both acetylationdependent and -independent mechanisms. We demonstrate that a novel function of acetylation is to shift the nucleocytoplasmic equilibrium of an activator toward the nucleus.
In a paper published prior to this submission, it is shown that acetylation by CBP is required for nuclear retention of hepatocyte nuclear factor 4 (48). 
